Engineered Living Component — Definition and Scope

An engineered living component is a living biological construct — cells, tissue, or a cell-device assembly — that is produced to a written specification and intended to function as a part within a larger system, rather than as an object of study in itself.

The three clauses each do work. Living excludes decellularised scaffolds, fixed tissue and synthetic mimics. Produced to a written specification excludes material that is merely collected, and excludes research output that is characterised after the fact rather than built to a target. Functions as a part within a larger system is the clause that distinguishes a component from an experiment: someone downstream is going to integrate it into something and needs it to behave predictably at an interface.

Why the category needed a name

Ask who sells engineered living components today and you get a list of companies that do not recognise each other as competitors: a reconstructed skin tissue manufacturer, a microfluidic device shop, a cell catalogue, an organ-on-chip platform, a muscle casting plate vendor. They are described in market reports under at least five different headings.

But a buyer with an engineering problem — a neurotechnology group needing an active neural culture, a biohybrid robotics laboratory needing a contractile actuator, a toxicology team needing a barrier tissue — is shopping across all of them for the same class of thing: a living part with a spec, delivered to a bench, that does a job.

That class had no name, and unnamed categories are hard to buy in. There is no comparison page, no normalised price, no shared vocabulary for specifying one. Naming it is the first step in making it purchasable.

Taxonomy

Class	Description	Specification is written in terms of	Commercial status today	Examples of the class
Cellular input	Cryopreserved cells supplied for the buyer to build with	Cell type, subtype, count, viability, purity, genotype, passage	Mature. Public catalogue prices from several suppliers	iPSC-derived cortical neurons, astrocytes, cardiomyocytes, skeletal myoblasts, iPSC lines
Finished barrier or spheroid tissue	Living, metabolically active tissue delivered ready to use	Tissue model, insert format, barrier function, viability on arrival, shelf life	Mature. A shipped product category roughly two decades old	Reconstructed human epidermis, airway and intestinal models, liver microtissues
Contractile tissue component	Force-generating, mechanically anchored muscle tissue	Absolute and specific force, cross-section, geometry, anchor type, stimulation response, maturation state	Partial. One supplier lists finished tissue with a price and a lead time (myriamed, EUR 1,400, 7–11 weeks), but no supplier publishes a force acceptance criterion, so the class cannot be specified in its own terms	Engineered skeletal muscle strips, engineered heart tissue on posts
Active neural culture	Neurons delivered plated, matured and electrically interrogable	Activity by DIV, network burst characteristics, electrode coupling, plate format	Absent as a delivered good. Cells are catalogue items; the maturation is the buyer’s problem	A plated, already-firing human network on an MEA plate
Cell-device assembly	Living material integrated into a housing, chip or fixture	All of the above, plus mechanical and fluidic interface, sterility of the assembly	Partial. Vendor-prepared perfused tissue models exist within closed platforms	Ready-to-use perfused tissue in a proprietary plate
Culture device (not itself an ELC)	The plasticware into which a buyer casts their own tissue	Geometry, material, feature size, well count, post stiffness	Mature, including public pricing and full custom microfabrication	Muscle casting plates, microfluidic chips, MEA plates
Native tissue to specification	Real animal or human tissue collected against a written spec	Species, anatomy, dimensions, age grade, preservation state	Mature and quote-driven. Under-known by engineers	Bovine tendon collected to a stated length and age grade

The two rows marked absent are the point of the taxonomy. The market splits three ways: epithelial and spheroid tissue is a shipped finished good; contractile muscle is available finished from one supplier (myriamed, EUR 1,400 per tissue) and as empty plasticware from several; and a construct released against a stated force acceptance criterion is sold by nobody. Every individual requirement for a force-specified contractile component — cells, mould, casting, stimulation, force testing, cold chain — is met by existing commercial capability. What does not exist is a party who will integrate them and warrant the object against a number.

Boundary cases: what is and is not an ELC

Case	ELC?	Reasoning
A vial of catalogue iPSC-derived cortical neurons	Yes, as a cellular input	Living, specified (subtype, count, viability, purity), and bought to be built into something
A reconstructed human epidermis tissue on an insert	Yes	Living, produced to a fixed specification, delivered as a functioning unit for a defined assay role
An engineered muscle strip cast to a stated twitch force with loop anchors	Yes, the canonical case	Specified functionally and mechanically, built to be integrated
An empty muscle-casting plate	No	Not living. It is the tooling for making an ELC, not the ELC
A decellularised ECM scaffold	No	Not living. It is a material input, and belongs to biomaterials
A cerebral organoid grown in an academic laboratory	Usually no	Organoids self-organise. Where the output is characterised after the fact rather than built to a target geometry and function, it is a model system, not a component. An organoid produced to a stated size, composition and activity criterion for integration into a device would qualify
A primary tumour biopsy	No	Collected, not engineered. Becomes an input to an ELC once processed to a spec
Bovine tendon collected to a stated length and age grade	Borderline; we include it	Not engineered in the constructive sense, but it is living-derived material supplied to a written specification for use as a mechanical part. It is frequently the correct and much cheaper answer where a passive component will do
A genetically modified bacterial strain producing a compound	No, under this definition	It is a production organism, not a part in a physical assembly. Synthetic biology, not ELC
An engineered T cell administered to a patient	No, under this definition	It is a therapeutic. The regulatory regime, the manufacturing standard and the buyer are all different. ELC is a research and engineering supply category
A live cell-based biosensor cartridge	Yes	Living, specified, and explicitly a component inside a larger instrument
A cell line, undifferentiated, sold as starting material	Yes, as the deepest cellular input	Specified by genotype, karyotype and pluripotency documentation, and bought to build from

The organoid row is the one most likely to be contested, so the reasoning deserves stating plainly: the distinguishing feature of a component is that its acceptance criteria are written before it is made. Self-organising systems are usually described after they are made. That is a difference in engineering posture, not a judgement about scientific value, and a given organoid programme can move across the line as its specifications tighten.

Relation to adjacent fields

Tissue engineering is the discipline. Engineered living components are one commercial output of it. Tissue engineering as a field is oriented largely toward regenerative medicine — building tissue for implantation into a patient. The ELC framing is oriented toward supply: building tissue as a purchasable part for research, testing and engineering use, with an acceptance criterion and a delivery date. Most of the science is shared; almost none of the commercial infrastructure is.

Biofabrication is a set of manufacturing methods — bioprinting, casting, moulding, directed assembly, self-assembly. It describes how an ELC gets made. A component is not defined by its fabrication route, and in practice the cheapest route to a given spec is often the least sophisticated one. Notably, the bioprinting service-bureau path has contracted rather than expanded in recent years, with prominent platform businesses in that segment shutting down.

Synthetic biology overlaps at the genetic layer and diverges at the physical one. Synthetic biology engineers the information inside a cell — circuits, pathways, expression programmes. ELC work engineers the object the cells constitute — its geometry, mechanics, interfaces and function as a part. A synthetic-biology-modified cell line can be the input to an ELC. A fermentation strain producing a molecule is not an ELC, because the deliverable is the molecule.

Organ-on-chip is a subset, specifically the cell-device assembly row of the taxonomy, with perfusion and, in every commercial platform we surveyed, inside a closed proprietary consumable. The platform lock-in is the defining commercial feature and the main reason organ-on-chip is often discussed separately from the components it contains.

Cultivated meat shares the entire supply chain — myogenic cells, scaffolds, media, scale — and diverges on the deliverable, which is bulk mass at food cost rather than a specified part at research cost. The cost targets differ by orders of magnitude, which is why techniques transfer between the fields but suppliers largely do not.

Why the definition is written this way

Three deliberate choices:

Specification-first, not method-first. A definition organised around how something is made would exclude the correct cheap answer to many engineering problems. A buyer who needs a passive tendon-like element should be routed to a native tissue supplier, not to a bioprinter. Defining by specification keeps that route inside the category.

Component, not model. The purpose clause — functioning as a part within a larger system — is what makes an acceptance test meaningful. If nobody downstream depends on the part, there is nothing to accept against, and the object is a model rather than a component. The distinction is what makes a spec enforceable, and an enforceable spec is the difference between a supply market and a referral network.

Living, without qualification about origin. Human, animal, immortalised, primary or iPSC-derived — all qualify. Origin is a specification field, not a category boundary.

Using the term

If you are specifying an ELC, the fields that matter are the ones a supplier needs to quote against: what it is made of, what geometry it takes, what it must do measurably, how it will be delivered, and how you will test it on arrival. We publish a structured format for that at the .wwd standard, and a field checklist in what belongs in a wetware RFQ.

The definition on this page is free to cite and free to criticise. If you think a boundary is drawn in the wrong place, that is a useful disagreement and we would rather have it in public than have the category stay unnamed.

Engineered living component (ELC): definition and scope